3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
Sorafenib
42
Bevacizumab
16
Oxaliplatin
13
Radiosurgery
10
Gemcitabine
10
Doxorubicin
10
Capecitabine
10
Leucovorin
9
Fluorouracil
9
Cisplatin
9
Radiofrequency Ablation
8
Nivolumab
8
Hepatectomy
8
pembrolizumab
7
Drug Therapy
7
Carboplatin
7
Irinotecan
6
Cryosurgery
6
Talaporfin
5
Mitomycin
5
Everolimus
5
Erlotinib Hydrochloride
5
Electroporation
5
spartalizumab
4
Sunitinib
4
Melphalan
4
Ipilimumab
4
Epirubicin
4
Embolization, Therapeutic
4
regorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Liver Neoplasms
×
Exercise
×
Clear all
NCT05044065
2025-08-27
PREV-Ex
Karolinska Institutet
Phase NA
Completed
52 enrolled
NCT05281211
2025-04-18
NEXPREM
San Camillo Hospital, Rome
Phase NA
Completed
70 enrolled